Last Updated On 9/28/2023 6:57:50 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Janssen |
Recipient: You |
Company: Mirati Therapeutics |
Recipient: You |
Company: Flare Therapeutics |
Recipient: You |
Company: Loxo/Lilly |
Recipient: You |
Company: Bicycle Therapeutics |
Recipient: You |
|
Speakers' Bureau |
Company: Gilead Sciences |
Recipient: You |
Company: The Lynx Group |
Recipient: You |
|
Research Funding |
Company: Mirati Therapeutics |
Recipient: Your Institution |
Company: Novartis |
Recipient: Your Institution |
Company: Debiopharm Group |
Recipient: Your Institution |
Company: Bayer |
Recipient: Your Institution |
Company: Janssen |
Recipient: Your Institution |
Company: Seagen |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|